Preparation for International Cooperation on Cosmetic Regulations; Public Meeting, 32798 [2010-13821]
Download as PDF
<![CDATA[
32798
Federal Register / Vol. 75, No. 110 / Wednesday, June 9, 2010 / Notices
DEPARTMENT OF HOMELAND
SECURITY
Food and Drug Administration
Freedom of Information (HFI–35), Office
of Management Programs, Food and
Drug Administration, 5600 Fishers
Lane, rm. 6–30, Rockville, MD 20857.
FDA–2010–N–0254
SUPPLEMENTARY INFORMATION:
The
purpose of the multilateral framework
on the ICCR is to pave the way for the
removal of regulatory obstacles to
international trade while maintaining
global consumer protection.
ICCR is a voluntary international
group of cosmetics regulatory
authorities from the United States,
Japan, the European Union, and Canada.
These regulatory authority members
will enter into constructive dialogue
with their relevant cosmetics’ industry
trade associations. Currently, the ICCR
members are Health Canada; the
European Directorate General for
Enterprise and Industry; the Ministry of
Health, Labor and Welfare of Japan; and
the U.S. Food and Drug Administration.
All decisions made by the consensus
will be compatible with the laws,
policies, rules, regulations, and
directives of the respective
administrations and governments.
Members will implement and/or
promote actions or documents within
their own jurisdictions and seek
convergence of regulatory policies and
practices. Successful implementation
will require input from stakeholders.
Interested persons may present data,
information, or views orally or in
writing, on issues pending at the public
meeting. Time allotted for oral
presentations may be limited to 10
minutes. Those desiring to make oral
presentations should notify the contact
person by July 2, 2010, and submit a
brief statement of the general nature of
the evidence or arguments they wish to
present, the names and addresses,
telephone number, fax, and e-mail of
proposed participants, and an
indication of the approximate time
requested to make their presentation.
The agenda for the public meeting
will be made available on the Internet
at: https://www.fda.gov/Cosmetics/
InternationalActivities/Conferences
MeetingsWorkshops.
Directorate for Management; DHS
Diversity Forum: Building a
Community for Women in the Federal
Government
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Preparation for International
Cooperation on Cosmetic Regulations;
Public Meeting
AGENCY:
Food and Drug Administration,
HHS.
erowe on DSK5CLS3C1PROD with NOTICES
ACTION:
Notice of meeting.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
public meeting entitled ‘‘International
Cooperation on Cosmetic Regulations
(ICCR)—Preparation for ICCR–4
Meetings in Toronto, Canada’’ to provide
information and receive comments on
the ICCR as well as the upcoming
meetings in Toronto, Canada. The topics
to be discussed are the topics for
discussion at the forthcoming ICCR
Steering Committee meeting. The
purpose of the meeting is to solicit
public input prior to the next Steering
Committee and expert working group
meetings in Toronto, Canada the week
of July 12, 2010.
Date and Time: The meeting will be
held on Wednesday, July 7, 2010, from
1:30 p.m. to 3:30 p.m.
Location: The meeting will be held in
the Washington Theater at the Hilton
Washington DC/Rockville Hotel &
Executive Meeting Center, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: All participants must
register with Jennifer Haggerty, Office of
the Commissioner, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 31, rm. 3567, Silver Spring,
MD 20903, 301–796–4600. Register by
emailing: jennifer.haggerty@fda.hhs.gov.
Registration and Requests for Oral
Presentations: Send registration
information (including name, title, firm
name, address, telephone, and fax
number), written material and requests
to make oral presentation, to the contact
person by July 2, 2010.
If you need special accommodations
due to a disability, please contact
Jennifer Haggerty (see Contact Person) at
least 7 days in advance.
Transcripts: Please be advised that as
soon as a transcript is available, it will
be accessible at https://
www.regulations.gov. It may be viewed
at the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD. A transcript will
also be available in either hardcopy or
on CD–ROM, after submission of a
Freedom of Information request. Written
requests are to be sent to Division of
VerDate Mar<15>2010
15:10 Jun 08, 2010
Jkt 220001
Dated: June 4, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–13821 Filed 6–8–10; 8:45 am]
BILLING CODE 4160–01–S
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
[Docket No. DHS–2010–0044]
AGENCY: Directorate for Management,
Office of the Chief Human Capital
Officer, DHS.
ACTION: Notice of meeting.
SUMMARY: On June 17, 2010, the
Department of Homeland Security
(DHS) Office of the Chief Human Capital
Officer will host a DHS Diversity
Forum: ‘‘Building a Community for
Women in the Federal Government.’’
The purpose of this forum is to identify
barriers and solutions for women in the
workplace. The event will feature panel
and roundtable discussions with women
from across government, DHS
components and outside organizations.
DATES: The meeting will take place on
Thursday, June 17, 2010, from 9:30 a.m.
to 4:30 p.m. This meeting may close
early if all business is finished.
ADDRESSES: The meeting will be held at
the National Museum of Women in the
Arts, 1250 New York Avenue, NW.,
Washington, DC 20005 in the Elizabeth
A. Kasser Board Room.
FOR FURTHER INFORMATION CONTACT: If
you have questions regarding this
notice, please contact DHS Diversity
Program Manager Patricia Trujillo via email at patricia.trujillo@hq.dhs.gov,
telephone at 202–357–8228, facsimile at
202–357–8140, or via mail to:
Department of Homeland Security,
Chief Human Capital Office, Mail Stop
0170, Diversity Program Manager, 245
Murray Lane, SW., Washington, DC
20528–0170.
SUPPLEMENTARY INFORMATION:
Background and Purpose: The
Department of Homeland Security
mission is to prevent terrorism and
enhance security, secure and manage
our borders, enforce and administer our
immigration laws, safeguard and secure
cyberspace, and ensure resilience to
disasters. DHS believes a diverse
workforce, led by dedicated
professionals who are representative of
the American people, is one of the keys
to mission success. DHS is committed to
making the vision of a fully
representative workforce a reality.
Procedural: This meeting is open to
the public. Due to space and other
facility constraints, however, the
meeting is limited to sixty-five
participants. To reserve a seat, please
send your RSVP to Patricia Trujillo at
E:\FR\FM\09JNN1.SGM
09JNN1
]]>Agencies
[Federal Register Volume 75, Number 110 (Wednesday, June 9, 2010)]
[Notices]
[Page 32798]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-13821]
[[Page 32798]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
FDA-2010-N-0254
Preparation for International Cooperation on Cosmetic
Regulations; Public Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing a public
meeting entitled ``International Cooperation on Cosmetic Regulations
(ICCR)--Preparation for ICCR-4 Meetings in Toronto, Canada'' to provide
information and receive comments on the ICCR as well as the upcoming
meetings in Toronto, Canada. The topics to be discussed are the topics
for discussion at the forthcoming ICCR Steering Committee meeting. The
purpose of the meeting is to solicit public input prior to the next
Steering Committee and expert working group meetings in Toronto, Canada
the week of July 12, 2010.
Date and Time: The meeting will be held on Wednesday, July 7, 2010,
from 1:30 p.m. to 3:30 p.m.
Location: The meeting will be held in the Washington Theater at the
Hilton Washington DC/Rockville Hotel & Executive Meeting Center, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: All participants must register with Jennifer
Haggerty, Office of the Commissioner, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 31, rm. 3567, Silver Spring, MD 20903,
301-796-4600. Register by emailing: jennifer.haggerty@fda.hhs.gov.
Registration and Requests for Oral Presentations: Send registration
information (including name, title, firm name, address, telephone, and
fax number), written material and requests to make oral presentation,
to the contact person by July 2, 2010.
If you need special accommodations due to a disability, please
contact Jennifer Haggerty (see Contact Person) at least 7 days in
advance.
Transcripts: Please be advised that as soon as a transcript is
available, it will be accessible at https://www.regulations.gov. It may
be viewed at the Division of Dockets Management (HFA-305), Food and
Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD. A
transcript will also be available in either hardcopy or on CD-ROM,
after submission of a Freedom of Information request. Written requests
are to be sent to Division of Freedom of Information (HFI-35), Office
of Management Programs, Food and Drug Administration, 5600 Fishers
Lane, rm. 6-30, Rockville, MD 20857.
SUPPLEMENTARY INFORMATION: The purpose of the multilateral framework on
the ICCR is to pave the way for the removal of regulatory obstacles to
international trade while maintaining global consumer protection.
ICCR is a voluntary international group of cosmetics regulatory
authorities from the United States, Japan, the European Union, and
Canada. These regulatory authority members will enter into constructive
dialogue with their relevant cosmetics' industry trade associations.
Currently, the ICCR members are Health Canada; the European Directorate
General for Enterprise and Industry; the Ministry of Health, Labor and
Welfare of Japan; and the U.S. Food and Drug Administration. All
decisions made by the consensus will be compatible with the laws,
policies, rules, regulations, and directives of the respective
administrations and governments. Members will implement and/or promote
actions or documents within their own jurisdictions and seek
convergence of regulatory policies and practices. Successful
implementation will require input from stakeholders.
Interested persons may present data, information, or views orally
or in writing, on issues pending at the public meeting. Time allotted
for oral presentations may be limited to 10 minutes. Those desiring to
make oral presentations should notify the contact person by July 2,
2010, and submit a brief statement of the general nature of the
evidence or arguments they wish to present, the names and addresses,
telephone number, fax, and e-mail of proposed participants, and an
indication of the approximate time requested to make their
presentation.
The agenda for the public meeting will be made available on the
Internet at: https://www.fda.gov/Cosmetics/InternationalActivities/ConferencesMeetingsWorkshops.
Dated: June 4, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-13821 Filed 6-8-10; 8:45 am]
BILLING CODE 4160-01-S
